Global Egg-Based Flu Vaccines Market Research Report 2025

Publication ID:

PB505257787

Publication Date:

May 30, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Egg-Based Flu Vaccines was valued at US$ 8102 million in the year 2024 and is projected to reach a revised size of US$ 11350 million by 2031, growing at a CAGR of 5.0% during the forecast period.
The most common way that flu vaccines are made is using an egg-based manufacturing process. that has been used for more than 70 years. Egg-based vaccine manufacturing is used to make both inactivated (killed) vaccine (usually called the 鈥渇lu shot鈥�) and live attenuated (weakened virus) vaccine (usually called the 鈥渘asal spray flu vaccine鈥�).
A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Egg-Based Flu Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Egg-Based Flu Vaccines.
The Egg-Based Flu Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Egg-Based Flu Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Egg-Based Flu Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Egg-Based Flu Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Egg-Based Flu Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Egg-Based Flu Vaccines Market Overview
1.1 Product Definition
1.2 Egg-Based Flu Vaccines by Type
1.2.1 Global Egg-Based Flu Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Egg-Based Flu Vaccines by Application
1.3.1 Global Egg-Based Flu Vaccines Market Value by Application (2024 VS 2031)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Egg-Based Flu Vaccines Market Size Estimates and Forecasts
1.4.1 Global Egg-Based Flu Vaccines Revenue 2020-2031
1.4.2 Global Egg-Based Flu Vaccines Sales 2020-2031
1.4.3 Global Egg-Based Flu Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Egg-Based Flu Vaccines Market Competition by Manufacturers
2.1 Global Egg-Based Flu Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Egg-Based Flu Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Egg-Based Flu Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Egg-Based Flu Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Egg-Based Flu Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Egg-Based Flu Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Egg-Based Flu Vaccines, Date of Enter into This Industry
2.8 Global Egg-Based Flu Vaccines Market Competitive Situation and Trends
2.8.1 Global Egg-Based Flu Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Egg-Based Flu Vaccines Players Market Share by Revenue
2.8.3 Global Egg-Based Flu Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Egg-Based Flu Vaccines Market Scenario by Region
3.1 Global Egg-Based Flu Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Egg-Based Flu Vaccines Sales by Region: 2020-2031
3.2.1 Global Egg-Based Flu Vaccines Sales by Region: 2020-2025
3.2.2 Global Egg-Based Flu Vaccines Sales by Region: 2026-2031
3.3 Global Egg-Based Flu Vaccines Revenue by Region: 2020-2031
3.3.1 Global Egg-Based Flu Vaccines Revenue by Region: 2020-2025
3.3.2 Global Egg-Based Flu Vaccines Revenue by Region: 2026-2031
3.4 North America Egg-Based Flu Vaccines Market Facts & Figures by Country
3.4.1 North America Egg-Based Flu Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Egg-Based Flu Vaccines Sales by Country (2020-2031)
3.4.3 North America Egg-Based Flu Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Egg-Based Flu Vaccines Market Facts & Figures by Country
3.5.1 Europe Egg-Based Flu Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Egg-Based Flu Vaccines Sales by Country (2020-2031)
3.5.3 Europe Egg-Based Flu Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Egg-Based Flu Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Egg-Based Flu Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Egg-Based Flu Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Egg-Based Flu Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Egg-Based Flu Vaccines Market Facts & Figures by Country
3.7.1 Latin America Egg-Based Flu Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Egg-Based Flu Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Egg-Based Flu Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Egg-Based Flu Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Egg-Based Flu Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Egg-Based Flu Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Egg-Based Flu Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Egg-Based Flu Vaccines Sales by Type (2020-2031)
4.1.1 Global Egg-Based Flu Vaccines Sales by Type (2020-2025)
4.1.2 Global Egg-Based Flu Vaccines Sales by Type (2026-2031)
4.1.3 Global Egg-Based Flu Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Egg-Based Flu Vaccines Revenue by Type (2020-2031)
4.2.1 Global Egg-Based Flu Vaccines Revenue by Type (2020-2025)
4.2.2 Global Egg-Based Flu Vaccines Revenue by Type (2026-2031)
4.2.3 Global Egg-Based Flu Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Egg-Based Flu Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Egg-Based Flu Vaccines Sales by Application (2020-2031)
5.1.1 Global Egg-Based Flu Vaccines Sales by Application (2020-2025)
5.1.2 Global Egg-Based Flu Vaccines Sales by Application (2026-2031)
5.1.3 Global Egg-Based Flu Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Egg-Based Flu Vaccines Revenue by Application (2020-2031)
5.2.1 Global Egg-Based Flu Vaccines Revenue by Application (2020-2025)
5.2.2 Global Egg-Based Flu Vaccines Revenue by Application (2026-2031)
5.2.3 Global Egg-Based Flu Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Egg-Based Flu Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Egg-Based Flu Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Egg-Based Flu Vaccines Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Egg-Based Flu Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Egg-Based Flu Vaccines Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Egg-Based Flu Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Egg-Based Flu Vaccines Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Egg-Based Flu Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Egg-Based Flu Vaccines Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Egg-Based Flu Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca Egg-Based Flu Vaccines Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Company Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Egg-Based Flu Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hualan Bio Egg-Based Flu Vaccines Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.7.1 Changchun Institute of Biological Company Information
6.7.2 Changchun Institute of Biological Description and Business Overview
6.7.3 Changchun Institute of Biological Egg-Based Flu Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Changchun Institute of Biological Egg-Based Flu Vaccines Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Company Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Egg-Based Flu Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinovac Egg-Based Flu Vaccines Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Company Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Egg-Based Flu Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BCHT Egg-Based Flu Vaccines Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Company Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Egg-Based Flu Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu GDK Egg-Based Flu Vaccines Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Company Information
6.11.2 KM Biologics Description and Business Overview
6.11.3 KM Biologics Egg-Based Flu Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 KM Biologics Egg-Based Flu Vaccines Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Egg-Based Flu Vaccines Industry Chain Analysis
7.2 Egg-Based Flu Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Egg-Based Flu Vaccines Production Mode & Process Analysis
7.4 Egg-Based Flu Vaccines Sales and Marketing
7.4.1 Egg-Based Flu Vaccines Sales Channels
7.4.2 Egg-Based Flu Vaccines Distributors
7.5 Egg-Based Flu Vaccines Customer Analysis
8 Egg-Based Flu Vaccines Market Dynamics
8.1 Egg-Based Flu Vaccines Industry Trends
8.2 Egg-Based Flu Vaccines Market Drivers
8.3 Egg-Based Flu Vaccines Market Challenges
8.4 Egg-Based Flu Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂